MDK7526 HCl salt form · salt · Parent VH032-NH2 · Synonyms: VHL ligand 1 hydrochloride | (S,R,S)-AHPC hydrochloride
MDK7526, also known as VHL Ligand 1; Protein degrader 1, is a potent and selective protein degrader.
For research use only. Not for human or veterinary use.
Target
Ligands for E3 Ligase
Research area
Cancer
Purity >98%
Stock Inquire
Description
MDK7526, also known as VHL Ligand 1; Protein degrader 1, is a potent and selective protein degrader.
Biological activity
In Vitro The VHL protein is a substrate recognition subunit of two ubiquitously expressed and biologically important Cullin RING E3 ubiquitin ligase complexes. VHL is one of the most popular E3 ligases being recruited by bifunctional Proteolysis-targeting chimeras (PROTACs) to induce ubiquitination and subsequent proteasomal degradation of a target protein.
Identifiers
- SMILES
-
Cl.CC1=C(SC=N1)C1=CC=C(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](N)C(C)(C)C)C=C1 - InChIKey
-
JYRTWGCWUBURGU-MSSRUXLCSA-N
Specifications
- MW (average)
- 467.0250
- Formula
- C22H31ClN4O3S
- CAS No.
- 1448189-80-7
- Physical state
- Solid
- Color
- white to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4℃ 2 years; -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO/H2O
Documents
References
[1]. Buckley DL, et al. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.ACS Chem Biol. 2015 Aug 21;10(8):1831-7.
[2]. Krieger J, et al. Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design. ChemMedChem. 2023 Apr 17;18(8):e202200615.
[3]. Vu LP, et al. Expanding the Structural Diversity at the Phenylene Core of Ligands for the von Hippel-Lindau E3 Ubiquitin Ligase: Development of Highly Potent Hypoxia-Inducible Factor-1α Stabilizers[J]. J Med Chem. 2023 Sep 28;66(18):12776-12811.
Same target
Search Ligands for E3 LigaseSame research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%